At Pairnomix, we are committed to better understanding rare genetic conditions and discovering new treatment options that are available today.
What We Do
Pairnomix offers personalized genetic evaluation services that enable physicians to practice precision medicine for their rare disease patients. Our services involve creating a laboratory model of a patient’s genetic mutation and conducting experiments to understand the precise effects of that mutation on cellular function. We then perform high-throughput drug screens to identify on-market drugs that could be repurposed to effectively treat the person’s condition. We provide our findings to the patient’s physician so together they can make better informed treatment decisions.
In this sense, Pairnomix is unique in that we are the only company working directly with families and their physicians to match patients to existing drugs that target their rare condition. We also have the capabilities to screen novel compounds in the genetic models we create and to pursue drug development and repurposing opportunities.
Opportunities for Collaboration
We actively seek partnerships with other organizations that share our goal of advancing knowledge of rare diseases and new treatment options. With our platform of rare genetic disease models, our networks of physicians and patient communities, and our extensive experience in genetic research and high throughput drug screening, we bring considerable expertise and resources to potential partners.
Pairnomix is already collaborating with a variety of companies and institutions in the rare CNS disorders space. To read about our partnership with StemoniX, please click here.
Please don’t hesitate to contact us with any inquiries into potential collaboration. We welcome the opportunity to discuss how Pairnomix may be able to work with your organization to achieve our mutual goals.